ESR1 and breast carcinoma: Interestingly, Kim et al. reported that miR-192-5p is regulated by lymphocyte antigen six complex (LY6K), which aggravates the progression of breast cancer by negatively correlating with the expression of ERα (Kim et al., 2016).